Filed: 5/15/2024ACC: 0001420506-24-001000
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 101 equity positions with a total reported market value of $959.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
101
Positions
$959.33M
Total AUM (reported)
71.79M
Total Shares
Allocation by class
COM$676.21M70.5%
COM NEW$134.50M14.0%
S&P BIOTECH$66.42M6.9%
SPONSORED ADR$20.95M2.2%
SPONSORED ADS$13.26M1.4%
COM PAR $.01$12.74M1.3%
SHS$8.34M0.9%
Portfolio Concentration
Top 3$197.13M20.5%
4–10$241.35M25.2%
11–25$243.40M25.4%
Rest$277.45M28.9%
Top 3 weight
20.5%
Top 10 weight
45.7%
Voting Authority Distribution
Total shares with voting rights: 71.79M
Sole
Full voting authority
71.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole101
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings101
Rows:
KRYSTAL BIOTECH INC
SOLEShares475K
TypeSH
Market value$84.52M
8.81%
Sole
475K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares700K
TypeSH
Market value$66.42M
6.92%
Sole
700K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares309.04K
TypeSH
Market value$46.19M
4.81%
Sole
309.04K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares952.85K
TypeSH
Market value$44.60M
4.65%
Sole
952.85K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares2M
TypeSH
Market value$43.42M
4.53%
Sole
2M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares268.38K
TypeSH
Market value$34.74M
3.62%
Sole
268.38K
Shared
0.00
None
0.00
CORCEPT THERAPEUTICS INC
SOLEShares1.27M
TypeSH
Market value$32.09M
3.35%
Sole
1.27M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares810.28K
TypeSH
Market value$29.45M
3.07%
Sole
810.28K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares471.57K
TypeSH
Market value$29.36M
3.06%
Sole
471.57K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares646.51K
TypeSH
Market value$27.67M
2.88%
Sole
646.51K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares559.27K
TypeSH
Market value$21.95M
2.29%
Sole
559.27K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares309.20K
TypeSH
Market value$20.95M
2.18%
Sole
309.20K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares671.41K
TypeSH
Market value$20.76M
2.16%
Sole
671.41K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares865.75K
TypeSH
Market value$17.89M
1.87%
Sole
865.75K
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares1.18M
TypeSH
Market value$17.65M
1.84%
Sole
1.18M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares245.15K
TypeSH
Market value$17.19M
1.79%
Sole
245.15K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares60K
TypeSH
Market value$17.06M
1.78%
Sole
60K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares515.20K
TypeSH
Market value$16.41M
1.71%
Sole
515.20K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$16.40M
1.71%
Sole
200K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares364.37K
TypeSH
Market value$14.44M
1.51%
Sole
364.37K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares51.40K
TypeSH
Market value$13.73M
1.43%
Sole
51.40K
Shared
0.00
None
0.00
INSMED INC
SOLEShares469.44K
TypeSH
Market value$12.74M
1.33%
Sole
469.44K
Shared
0.00
None
0.00
MACROGENICS INC
SOLEShares841.67K
TypeSH
Market value$12.39M
1.29%
Sole
841.67K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares223.70K
TypeSH
Market value$12.23M
1.28%
Sole
223.70K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares654K
TypeSH
Market value$11.62M
1.21%
Sole
654K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KRYSTAL BIOTECH INCSOLE | COM | 475K | SH | $84.52M 8.81% | 475K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 700K | SH | $66.42M 6.92% | 700K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 309.04K | SH | $46.19M 4.81% | 309.04K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 952.85K | SH | $44.60M 4.65% | 952.85K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 2M | SH | $43.42M 4.53% | 2M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 268.38K | SH | $34.74M 3.62% | 268.38K | 0.00 | 0.00 |
CORCEPT THERAPEUTICS INCSOLE | COM | 1.27M | SH | $32.09M 3.35% | 1.27M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 810.28K | SH | $29.45M 3.07% | 810.28K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 471.57K | SH | $29.36M 3.06% | 471.57K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 646.51K | SH | $27.67M 2.88% | 646.51K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 559.27K | SH | $21.95M 2.29% | 559.27K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 309.20K | SH | $20.95M 2.18% | 309.20K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 671.41K | SH | $20.76M 2.16% | 671.41K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 865.75K | SH | $17.89M 1.87% | 865.75K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 1.18M | SH | $17.65M 1.84% | 1.18M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 245.15K | SH | $17.19M 1.79% | 245.15K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 60K | SH | $17.06M 1.78% | 60K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 515.20K | SH | $16.41M 1.71% | 515.20K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 200K | SH | $16.40M 1.71% | 200K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 364.37K | SH | $14.44M 1.51% | 364.37K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 51.40K | SH | $13.73M 1.43% | 51.40K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 469.44K | SH | $12.74M 1.33% | 469.44K | 0.00 | 0.00 |
MACROGENICS INCSOLE | COM | 841.67K | SH | $12.39M 1.29% | 841.67K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 223.70K | SH | $12.23M 1.28% | 223.70K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 654K | SH | $11.62M 1.21% | 654K | 0.00 | 0.00 |
Page 1 of 5
…